心脏淀粉样变性与结节病的放射性核素显像:各种示踪剂的作用与特征
本文综述心脏淀粉样变性与心脏结节病放射性核素显像的示踪剂选择与影像特征。骨显像剂对转甲状腺素蛋白型淀粉样变性敏感,PET淀粉样变显像剂对轻链型亲和力更高;镓67枸橼酸显像与氟18脱氧葡萄糖PET是心脏结节病诊断关键,后者疗效监测效能高,但心肌生理性摄取可在约20%患者中持续存在。
要点
- 骨显像剂对转甲状腺素蛋白型心脏淀粉样变性检测敏感,PET淀粉样变显像剂对轻链型亲和力更高。
- 氟18脱氧葡萄糖PET/CT检测心脏结节病及监测治疗反应效能高。
- 即使经精细准备,约20%患者心肌仍存在氟18脱氧葡萄糖生理性摄取,为重要局限。
关键影像表现/征象
- 淀粉样变性以淀粉样纤维沉积为特征,心脏淀粉样变性分为免疫球蛋白轻链型(AL)与转甲状腺素蛋白型(ATTR)。
- 淀粉样变性示踪剂包括骨显像剂、淀粉样变靶向分子和PET淀粉样变显像剂。
- 骨显像剂检测ATTR型淀粉样变性特别敏感,PET淀粉样变显像剂对AL型显示更高亲和力。
- 心脏结节病中,镓67枸橼酸闪烁显像与氟18脱氧葡萄糖PET对诊断至关重要,氟18脱氧葡萄糖PET/CT检测结节病及监测治疗反应效能特别高。
诊断标准与关键数值
- 原文未给出敏感度、特异度、AUC、阈值或分级标准的具体数值。
- 氟18脱氧葡萄糖的主要局限为心肌生理性摄取,即使经精细准备(如延长禁食>12-18小时、改为高脂低碳水化合物饮食、注射普通肝素),约20%患者仍可存在。
临床应用与阅片要点
- 心脏淀粉样变性显像示踪剂选择需区分AL型与ATTR型:骨显像剂对ATTR型敏感,PET淀粉样变显像剂对AL型亲和力更高。
- 心脏结节病诊断可用镓67枸橼酸闪烁显像与氟18脱氧葡萄糖PET,氟18脱氧葡萄糖PET/CT对检测结节病及监测治疗反应效能特别高。
- 判读氟18脱氧葡萄糖PET时需注意心肌生理性摄取,即使延长禁食>12-18小时、高脂低碳水化合物饮食及注射普通肝素后,约20%患者仍可存在。
- 生长抑素受体显像与细胞增殖显像等新示踪剂无需饮食限制即可达到与氟18脱氧葡萄糖相当的检出能力,并可能用于监测疾病活动性。
局限性
- 氟18脱氧葡萄糖的主要局限为心肌生理性摄取,即使经精细准备(如延长禁食>12-18小时、改为高脂低碳水化合物饮食、注射普通肝素),约20%患者仍可存在。
- 该局限促使人们寻找潜在的新示踪剂。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Amyloidosis and sarcoidosis are systemic diseases that affect multiple organ systems. Accurate diagnosis of cardiac amyloidosis and sarcoidosis is particularly important because cardiac involvement can be fatal. Amyloidosis is characterized by the deposition of amyloid fibrils, and cardiac amyloidosis is classified into amyloid immunoglobulin light chain (AL) and amyloid transthyretin (ATTR) types. Radionuclide tracers for amyloidosis include (a) bone tracers, (b) amyloid-directed molecules, and (c) PET amyloid agents. Bone tracers are particularly sensitive in detection of ATTR type amyloidosis, whereas PET amyloid agents show a higher affinity for the AL type. In sarcoidosis, gallium 67 (67Ga) citrate scintigraphy and fluorine 18 (18F) fluorodeoxyglucose (FDG) PET are pivotal to diagnosis of cardiac sarcoidosis, and 18F-FDG PET/CT has particularly high efficacy in detection of sarcoidosis and monitoring of response to therapy. A major limitation of 18F-FDG is physiologic uptake in the myocardium, which can remain in approximately 20% of patients even after elaborate preparation (eg, prolonged fasting >12-18 hours, modification to a high-fat and low-carbohydrate diet, and injection of unfractionated heparin). This limitation has led to a search for potential new tracers. Recently introduced tracers that show promise include those used in somatostatin receptor imaging and cellular proliferation imaging, which provide detectability as high as that for 18F-FDG without requiring dietary restrictions and have potential for monitoring disease activity. ©RSNA, 2020.
引用
- Hotta M, Minamimoto R, Awaya T, et al. Radionuclide Imaging of Cardiac Amyloidosis and Sarcoidosis: Roles and Characteristics of Various Tracers. Radiographics. 2020. PMID: 32976061. doi:10.1148/rg.2020200068
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。